Skip to main content
2 liquid biopsy tests debuted by Qiagen
4/16/2018

Two liquid biopsy panels were launched by Qiagen for use in assessing circulating tumor cells isolated from blood samples. The AdnaTest LungCancer kit determines CTCs involved in cancer growth and in a cancer therapy resistance marker called epithelial-mesenchymal transition, while the AdnaTest ProstateCancerPanel kit evaluates resistance to drugs for advanced prostate cancer as it spots the androgen receptor splice variant 7 in CTCs of prostate tumor origin.

Full Story: